MannKind Announced That It Has Repaid In Full All Outstanding Indebtedness Under Both Its Credit And Security Agreement With Midcap Financial Trust And Its Convertible Promissory Note Issued To Mann Group LLC
$MNKD
Biotechnology: Pharmaceutical Preparations
Health Care
- Credit and security agreement with MidCap Financial Trust repaid in full for approximately $31.6 million
- Convertible note issued to Mann Group LLC repaid in exchange for 1.5 million shares of common stock and approximately $8.9 million
- Total debt reduced since December 31, 2023 is approximately $41.8 million